Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-101718
Filing Date
2009-05-06
Accepted
2009-05-06 17:17:20
Documents
6
Period of Report
2009-03-28

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 215137
2 EMPLOYMENT AGREEMENT BETWEEN NABI BIOPHARMACEUTICALS AND MATTHEW KALNIK, PH.D. dex101.htm EX-10.1 35572
3 CHANGE OF CONTROL SEVERANCE AGREEMENT BETWEEN NABI BIO. AND MATTHEW KALNIK dex102.htm EX-10.2 26168
4 SECTION 302 CEO AND CFO CERTIFICATION dex31.htm EX-31 9376
5 SECTION 906 CEO AND CFO CERTIFICATION dex32.htm EX-32 3136
6 GRAPHIC g70716ex10_2pg1.jpg GRAPHIC 8333
  Complete submission text file 0001193125-09-101718.txt   302686
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
Type: 10-Q | Act: 34 | File No.: 000-04829 | Film No.: 09802466
SIC: 2836 Biological Products, (No Diagnostic Substances)